M'liss A Hudson, MD - Medicare Urology in Longview, TX

M'liss A Hudson, MD is a medicare enrolled "Urology" physician in Longview, Texas. She went to University Of Texas Medical School At Houston and graduated in 1982 and has 42 years of diverse experience with area of expertise as Urology. She is a member of the group practice Mercy Clinic Springfield Communities and her current practice location is 802 Medical Dr, Suite 400, Longview, Texas. You can reach out to her office (for appointments etc.) via phone at (903) 757-7871.

M'liss A Hudson is licensed to practice in Texas (license number G3482) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1790847994.

Contact Information

M'liss A Hudson, MD
802 Medical Dr, Suite 400,
Longview, TX 75605-5100
(903) 757-7871
(903) 753-2479



Physician's Profile

Full NameM'liss A Hudson
GenderFemale
SpecialityUrology
Experience42 Years
Location802 Medical Dr, Longview, Texas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • M'liss A Hudson attended and graduated from University Of Texas Medical School At Houston in 1982
  NPI Data:
  • NPI Number: 1790847994
  • Provider Enumeration Date: 12/14/2006
  • Last Update Date: 03/30/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 1456446244
  • Enrollment ID: I20071009000707

Medical Identifiers

Medical identifiers for M'liss A Hudson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1790847994NPI-NPPES
123023705MedicaidTX
02005302MedicaidMS
2307941MedicaidLA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology MD.205535 (Louisiana)Secondary
208800000XUrology R8H73 (Missouri)Secondary
208800000XUrology G3482 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mercy Hospital SpringfieldSpringfield, MOHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mercy Clinic Springfield Communities7416865845922

News Archive

NCCN announces new guidelines for patients with pancreatic Cancer

The National Comprehensive Cancer Network (NCCN), with the support of the Pancreatic Cancer Action Network, announces the latest addition to the library of NCCN Guidelines for PatientsTM, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology.

Examining global partnerships on World Health Day

Noting Sunday "was World Health Day, and marked the 65th anniversary of the founding of the World Health Organization," Andrea Durkin, senior director of global government affairs and policy for Abbott, writes in the U.S. Global Leadership Coalition blog.

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

Shire announces new pharmacokinetic data of ADHD medication

Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.

Microbe screening and sorting device created by researchers

Researchers have made a device that could sour the waters of the seas for microbes and also detect which of these could develop antimicrobial resistance. This could quantify the threat they pose to the ecosystems. This portable device and the trial with it were reported in the latest issue of the journal Scientific Reports. The study was titled, "Electrical impedance as an indicator of microalgal cell health."

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. M'liss A Hudson allows following entities to bill medicare on her behalf.
Entity NameMercy Clinic Springfield Communities
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245277631
PECOS PAC ID: 7416865845
Enrollment ID: O20031104000060

News Archive

NCCN announces new guidelines for patients with pancreatic Cancer

The National Comprehensive Cancer Network (NCCN), with the support of the Pancreatic Cancer Action Network, announces the latest addition to the library of NCCN Guidelines for PatientsTM, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology.

Examining global partnerships on World Health Day

Noting Sunday "was World Health Day, and marked the 65th anniversary of the founding of the World Health Organization," Andrea Durkin, senior director of global government affairs and policy for Abbott, writes in the U.S. Global Leadership Coalition blog.

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

Shire announces new pharmacokinetic data of ADHD medication

Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.

Microbe screening and sorting device created by researchers

Researchers have made a device that could sour the waters of the seas for microbes and also detect which of these could develop antimicrobial resistance. This could quantify the threat they pose to the ecosystems. This portable device and the trial with it were reported in the latest issue of the journal Scientific Reports. The study was titled, "Electrical impedance as an indicator of microalgal cell health."

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. M'liss A Hudson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
M'liss A Hudson, MD
Po Box 847176,
Dallas, TX 75284-7176

Ph: (903) 237-1800
M'liss A Hudson, MD
802 Medical Dr, Suite 400,
Longview, TX 75605-5100

Ph: (903) 757-7871

News Archive

NCCN announces new guidelines for patients with pancreatic Cancer

The National Comprehensive Cancer Network (NCCN), with the support of the Pancreatic Cancer Action Network, announces the latest addition to the library of NCCN Guidelines for PatientsTM, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology.

Examining global partnerships on World Health Day

Noting Sunday "was World Health Day, and marked the 65th anniversary of the founding of the World Health Organization," Andrea Durkin, senior director of global government affairs and policy for Abbott, writes in the U.S. Global Leadership Coalition blog.

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

Shire announces new pharmacokinetic data of ADHD medication

Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.

Microbe screening and sorting device created by researchers

Researchers have made a device that could sour the waters of the seas for microbes and also detect which of these could develop antimicrobial resistance. This could quantify the threat they pose to the ecosystems. This portable device and the trial with it were reported in the latest issue of the journal Scientific Reports. The study was titled, "Electrical impedance as an indicator of microalgal cell health."

Read more News

› Verified 9 days ago


Urology Doctors in Longview, TX

Adrienne J K Carmack, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 703 E Marshall Ave, Suite 5007, Longview, TX 75601
Phone: 903-315-4455    Fax: 903-315-2466
Dr. Paul Brian Williams, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 802 Medical Dr, Longview, TX 75605
Phone: 903-757-7871    Fax: 903-753-2479
Landon Taylor Erickstad, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 802 Medical Dr Ste 400, Longview, TX 75605
Phone: 903-757-7871    Fax: 903-753-2479
Dr. John M Ferrell, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 703 E Marshall Ave, Suite 5008, Longview, TX 75601
Phone: 903-757-7871    Fax: 903-753-2479
Gid Roger Johnson, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 1608 Sweetbriar St, Longview, TX 75604
Phone: 903-297-6000    Fax: 903-297-6250
Dr. Gregory Ashton Edwards, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 802 Medical Dr, Suite 400, Longview, TX 75605
Phone: 903-757-7871    Fax: 903-753-2479
Dr. Timothy W Howes, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 703 E Marshall Ave, Suite 5008, Longview, TX 75601
Phone: 903-757-7871    Fax: 903-753-2479

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.